Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders H Kverneland

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Seminars in Immunopathology|January 4, 2023
Proteomics to study cancer immunity and improve treatmentGiulia Franciosa, Anders H Kverneland, Agnete W P Jensen, et al.
Proteomics|November 18, 2022
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesiclesAnders H Kverneland, Ole Østergaard, Kristina Bennet Emdal, et al.
Cytotherapy|May 2, 2021
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibitionAnders H Kverneland, Troels Holz Borch, Joachim Granhøj, et al.
Oncoimmunology|May 4, 2018
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumabAnders H Kverneland, Christian Enevold, Marco Donia, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 5, 2016
Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocolAnders H Kverneland, Mathias Streitz, Edward Geissler, et al.
Molecular & Cellular Proteomics : MCP|May 22, 2024
Fully Automated Workflow for Integrated Sample Digestion and Evotip Loading Enabling High-Throughput Clinical ProteomicsAnders H Kverneland, Florian Harking, Joel Mario Vej-Nielsen, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Seminars in Immunopathology|January 4, 2023
Proteomics to study cancer immunity and improve treatmentGiulia Franciosa, Anders H Kverneland, Agnete W P Jensen, et al.
Proteomics|November 18, 2022
Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesiclesAnders H Kverneland, Ole Østergaard, Kristina Bennet Emdal, et al.
Cytotherapy|May 2, 2021
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibitionAnders H Kverneland, Troels Holz Borch, Joachim Granhøj, et al.
Oncoimmunology|May 4, 2018
Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumabAnders H Kverneland, Christian Enevold, Marco Donia, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 5, 2016
Age and gender leucocytes variances and references values generated using the standardized ONE-Study protocolAnders H Kverneland, Mathias Streitz, Edward Geissler, et al.
Molecular & Cellular Proteomics : MCP|May 22, 2024
Fully Automated Workflow for Integrated Sample Digestion and Evotip Loading Enabling High-Throughput Clinical ProteomicsAnders H Kverneland, Florian Harking, Joel Mario Vej-Nielsen, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF<sup>®</sup>09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Pageof 1